Age‐related differences in the immune response could contribute to determine the spectrum of severity of COVID‐19
Open Access
- 10 February 2021
- journal article
- review article
- Published by Wiley in Immunity, Inflammation and Disease
- Vol. 9 (2), 331-339
- https://doi.org/10.1002/iid3.404
Abstract
Coronavirus disease 2019 (COVID‐19), can present with a wide spectrum of severity. Elderly patients with cardiac, pulmonary and metabolic comorbidities are more likely to develop the severe manifestations of COVID‐19, which are observed in less than 5% of the pediatric patients. Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is able to induce an immune impairment and dysregulation, finally resulting in the massive release of inflammatory mediators, strongly contributing to the pulmonary and systemic manifestations in COVID‐19. In children, the immune dysregulation following SARS‐CoV‐2 can also be responsible of a severe disease phenotype defined as multisystem inflammatory syndrome in children. As the immune system undergoes a complex process of maturation from birth to adult age, differences in the immune and inflammatory response could have a significant impact in determining the spectrum of severity of COVID‐19. Indeed, children show a higher ability to respond to viral infections and a reduced baseline pro‐inflammatory state compared with elderly patients. Age and comorbidities contribute to disease severity through immune‐mediated mechanisms, since they are associated with a chronic increase of pro‐inflammatory mediators, and cause an enhanced susceptibility to develop an immune dysregulation following SARS‐CoV‐2 infection. Also the expression of ACE2, the receptor of SARS‐CoV‐2, varies with age, and is linked to the immune and inflammatory response through a complex, and not completely elucidated, network. This paper reviews the peculiar immunopathogenic aspects of COVID‐19, with a focus on the differences between adult and pediatric patients.Keywords
This publication has 76 references indexed in Scilit:
- Obesity, inflammation and the immune systemProceedings of the Nutrition Society, 2012
- T Cell Responses Are Required for Protection from Clinical Disease and for Virus Clearance in Severe Acute Respiratory Syndrome Coronavirus-Infected MiceJournal of Virology, 2010
- The Aging Immune System and Its Relationship to the Development of Chronic Obstructive Pulmonary DiseaseProceedings of the American Thoracic Society, 2009
- B cells and aging: molecules and mechanismsTrends in Immunology, 2009
- CD28− T cells: their role in the age-associated decline of immune functionTrends in Immunology, 2009
- Mechanisms of immunosenescenceImmunity & Ageing, 2009
- Interferon-Mediated Immunopathological Events Are Associated with Atypical Innate and Adaptive Immune Responses in Patients with Severe Acute Respiratory SyndromeJournal of Virology, 2007
- Expression of elevated levels of pro‐inflammatory cytokines in SARS‐CoV‐infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARSThe Journal of Pathology, 2006
- Age- and gender-related difference of ACE2 expression in rat lungLife Sciences, 2006
- Accumulation of memory T cells from childhood to old age: Central and effector memory cells in CD4+ versus effector memory and terminally differentiated memory cells in CD8+ compartmentMechanisms of Ageing and Development, 2006